Mumbai-based revenue cycle management (RCM) solutions provider Infinx announced the acquisition of healthcare RCM business of US-based i3 Verticals, including its associated proprietary technology for $96 million (around Rs 800 crore) to help expand its presence in academic medical centers.
“The transaction strengthens Infinx’s market presence in the healthcare RCM space and expands its footprint into new customer segments, including academic medical centers and other large provider groups,” Infinx said in a statement.
The deal is subject to post-closing purchase price adjustments.
The purchase comes in less than two months of its acquisition of US-based prior authorisation processing firm Glidian for an undisclosed amount to grow the laboratory market.
“Their deep experience supporting academic medical centers and the strong relationships they’ve built over the years are an ideal complement to our technology-driven approach,” said Jaideep Tandon, chairman and CEO of Infinx. “By combining their trusted expertise with our AI-powered RCM Insights, patient access, and automation platforms, we’re excited to deliver meaningful financial and clinical outcomes for healthcare providers nationwide,” he added.
The outsourced RCM services market was valued at approximately $20 billion in 2023 and expected to grow at a 12% compound annual growth rate (CAGR) till 2029, as per a recent report by investment banking and asset management firm Avendus Capital.
Established in 2012, Infinx provides AI-driven solutions that optimise the financial lifecycle of healthcare providers, covering patient access and revenue cycle management.
“The transaction strengthens Infinx’s market presence in the healthcare RCM space and expands its footprint into new customer segments, including academic medical centers and other large provider groups,” Infinx said in a statement.
The deal is subject to post-closing purchase price adjustments.
The purchase comes in less than two months of its acquisition of US-based prior authorisation processing firm Glidian for an undisclosed amount to grow the laboratory market.
“Their deep experience supporting academic medical centers and the strong relationships they’ve built over the years are an ideal complement to our technology-driven approach,” said Jaideep Tandon, chairman and CEO of Infinx. “By combining their trusted expertise with our AI-powered RCM Insights, patient access, and automation platforms, we’re excited to deliver meaningful financial and clinical outcomes for healthcare providers nationwide,” he added.
The outsourced RCM services market was valued at approximately $20 billion in 2023 and expected to grow at a 12% compound annual growth rate (CAGR) till 2029, as per a recent report by investment banking and asset management firm Avendus Capital.
Established in 2012, Infinx provides AI-driven solutions that optimise the financial lifecycle of healthcare providers, covering patient access and revenue cycle management.
You may also like
Trump administration invokes state secrets privilege in deportation case of Kilmar Abrego Garcia
Haunting images of doomed New York helicopter wreckage after crash kills six people
Florida woman killed by alligator during canoe trip as husband desperately tried to save her
Shahid Kapoor: Shahid Kapoor posted on Operation Sindoor, did he later edit and close the comment section?
Two officers injured as pro-Palestinian protesters occupy Columbia University library: What we know so far
